DSP Nifty Healthcare Index Fund
The scheme seeks to generate returns that are commensurate with the performance of the Nifty Healthcare Index, subject to tracking error.
Growthvine rating: 1/5 — ranked #209 of 245 in category.
Fund basics
| Category | Equity: Index |
|---|
| NAV | ₹10.85 (as of 2026-10-23) |
|---|
| AUM | ₹25 Cr |
|---|
| Expense ratio | 0.80% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Anil Ghelani |
|---|
| Exit load | 0 |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −9.29% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Market cap allocation
| Large cap | 47.8% |
|---|
| Mid cap | 48.4% |
|---|
| Small cap | 3.8% |
|---|
Concentration
| Top 5 holdings | 48.4% |
|---|
| Top 10 holdings | 75.9% |
|---|
| Total holdings | 20 |
|---|
Top holdings
- Sun Pharmaceutical Industries Ltd. — 17.0%
- Divis Laboratories Ltd. — 10.4%
- Apollo Hospitals Enterprises Ltd. — 7.4%
- Laurus Labs Limited — 6.8%
- Cipla Ltd. — 6.7%
- Dr. Reddys Laboratories Ltd. — 6.7%
- Torrent Pharmaceuticals Ltd. — 6.3%
- Max Healthcare Institute Limited — 6.1%
- Lupin Ltd — 4.4%
- Aurobindo Pharma Ltd. — 4.1%
Top sectors
- Pharma & Biotech — 81.2%
- Healthcare — 18.9%
- Cash — −0.0%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 4.9% | — | — |